EI
IMGN

EAM Investors’s Immunogen Inc IMGN Stock Holding History

EAM Investors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-155,429
Closed -$2.47M – 400
2023
Q3 		$2.47M Sell
155,429
-37,090
-19% -$617K 0.48% 66
2023
Q2 		$3.63M Buy
+192,519
New +$2.27M 0.67% 21
2018
Q2 		– Sell
-375,205
Closed -$3.95M – 371
2018
Q1 		$3.95M Buy
+375,205
New +$3.71M 0.66% 26
2017
Q4 		– Sell
-590,708
Closed -$4.52M – 361
2017
Q3 		$4.52M Buy
590,708
+7,843
+1% +$52.1K 0.6% 38
2017
Q2 		$4.14M Buy
+582,865
New +$2.67M 0.69% 19

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

EAM Investors's IMGN Position: Q4 2023 in Review

EAM Investors sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 155,429 shares — an estimated $2.47M sold.

EAM Investors first reported a position in IMGN in Q2 2017 and held it in 5 quarters. The position peaked at $4.52M in Q3 2017. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • EAM Investors reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • EAM Investors sold 155,429 Immunogen Inc shares in Q4 2023, an estimated $2.47M.
  • EAM Investors first reported a position in Immunogen Inc in Q2 2017 and held it in 5 quarters.
  • EAM Investors's Immunogen Inc position peaked at $4.52M in Q3 2017.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on EAM Investors's 13F filing for Q4 2023, filed 14 Feb 2024.